Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
The DOI matches its Crossref record; 360 of the 360 references it cites were found in a registry or an index.
Abstract
This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care–associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies, however, did not observe an association between antimicrobial timing and mortality (112-117).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [113]
In the citing paper
“patients with febrile neutropenia who fail to defervesce after 4–7 days of broad-spectrum antibacterial therapy are at increased risk of having fungal disease (Table 2) [175, 176].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [175]
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Self-citationSiegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationBODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
Guideline for hand hygiene in health-care settings
Boyce, J. M., & Pittet, D. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.130391 · Cited by 2,120
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Maki, D. G., Kluger, D. M., & Crnich, C. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1159 · Cited by 1,549
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E., & Lyman, G. H. (2006) · Cancer · doi:10.1002/cncr.21847 · Cited by 1,176
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Klastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Self-citationMoore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,078
Boyce, J. M., & Pittet, D. (2002) · PubMed · Cited by 1,047
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citationDiagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
(2006) · PubMed · Cited by 906
The Agent of Bacillary Angiomatosis: An Approach to the Identification of Uncultured Pathogens
Relman, D. A., Loutit, J. S., Schmidt, T. M., Falkow, S., & Tompkins, L. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012063232301 · Cited by 901
Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Clinical Practice Guidelines: Directions for a New Program
Committee to Advise the Public Health Service on Clinical Practice Guidelines, & Institute of Medicine (1990) · National Academies Press eBooks · doi:10.17226/1626 · Cited by 803
Raad, I. I., Hohn, D. C., Gilbreath, B. J., Suleiman, N., Hill, L. A., Bruso, P. A., Marts, K., Mansfield, P. F., & Bodey, G. P. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646902 · Cited by 774
Self-citationGERSON, S. L., TALBOT, G. H., HURWITZ, S., STROM, B. L., LUSK, E. J., & CASSILETH, P. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-345 · Cited by 763
van Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 744
Kuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374339 · Cited by 687
Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
Self-citationLevofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M. S., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044097 · Cited by 648
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
Kollef, M. H. (2000) · Clinical Infectious Diseases · doi:10.1086/314079 · Cited by 635
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
(2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70002-4 · Cited by 607
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J.-W., Stark, P., Durand, C., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 594
Self-citationMaertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., & Lietman, P. S. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107093050202 · Cited by 591
Caillot, D., Couaillier, J.-F., Bernard, A., Casasnovas, O., Denning, D. W., Mannone, L., Lopez, J., Couillault, G., Piard, F., Vagner, O., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.253 · Cited by 587
Pizzo, P. A., Hathorn, J. W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150905 · Cited by 585
Raad, I., Costerton, W., Sabharwal, U., Sadlowski, M., Anaissie, E., & Bodey, G. P. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.400 · Cited by 553
Self-citationDetection of Bloodstream Infections in Adults: How Many Blood Cultures Are Needed?
Lee, A., Mirrett, S., Reller, L. B., & Weinstein, M. P. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01555-07 · Cited by 548
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Talcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Aapro, M. S., Cameron, D. A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G. H., Tjan-Heijnen, V. C., Walewski, J., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.002 · Cited by 539
Wingard, J. R., White, M. H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 527
Self-citationKullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521
Kunisaki, K. M., & Janoff, E. N. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70175-6 · Cited by 516
Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Self-citationMeta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
Gafter-Gvili, A., Fraser, A., Paul, M., & Leibovici, L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00008 · Cited by 499
Galactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
The Periodic Health Examination
(1934) · New England Journal of Medicine · doi:10.1056/nejm193401252100413 · Cited by 483
Marr, K. A., Balajee, S. A., McLaughlin, L., Tabouret, M., Bentsen, C., & Walsh, T. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/422009 · Cited by 483
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
Marr, K. A., Laverdiere, M., Gugel, A., & Leisenring, W. (2005) · Clinical Infectious Diseases · doi:10.1086/429921 · Cited by 471
Angiogenic and HIV-Inhibitory Functions of KSHV-Encoded Chemokines
Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., et al. (1997) · Science · doi:10.1126/science.278.5336.290 · Cited by 469
Kuhlman, J. E., Fishman, E. K., & Siegelman, S. S. (1985) · Radiology · doi:10.1148/radiology.157.3.3864189 · Cited by 448
Marr, K. A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2004) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 442
Self-citationFowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Blot, F., Nitenberg, G., Chachatty, E., Raynard, B., Germann, N., Antoun, S., Laplanche, A., Brun-Buisson, C., & Tancrède, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11134-0 · Cited by 438
Optimal Testing Parameters for Blood Cultures
Cockerill, F. R., Wilson, J. W., Vetter, E. A., Goodman, K. M., Torgerson, C. A., Harmsen, W. S., Schleck, C. D., Ilstrup, D. M., Washington, J. A., & Wilson, W. R. (2004) · Clinical Infectious Diseases · doi:10.1086/421087 · Cited by 435
Rosenberg, P. S. (2006) · Blood · doi:10.1182/blood-2005-11-4370 · Cited by 431
Revisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050078 · Cited by 422
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Zinner, S. H. (1999) · Clinical Infectious Diseases · doi:10.1086/598620 · Cited by 417
Freifeld, A., Marchigiani, D., Walsh, T., Chanock, S., Lewis, L., Hiemenz, J., Hiemenz, S., Hicks, J. E., Gill, V., Steinberg, S. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410501 · Cited by 402
Self-citationAspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K.-L., Natarajan-Amé, S., Lutz, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.004 · Cited by 392
Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 389
Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suarez, F., Dhédin, N., Isnard, F., Ades, L., Kuhnowski, F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597395 · Cited by 389
Elting, L. S., Rubenstein, E. B., Rolston, K. V. I., & Bodey, G. P. (1997) · Clinical Infectious Diseases · doi:10.1086/514550 · Cited by 385
Self-citationAntimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Elting, L. S., Bodey, G. P., & Keefe, B. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1201 · Cited by 377
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Nichols, W. G., Guthrie, K. A., Corey, L., & Boeckh, M. (2004) · Clinical Infectious Diseases · doi:10.1086/425004 · Cited by 377
Self-citationKern, W. V., Cometta, A., de Bock, R., Langenaeken, J., Paesmans, M., Zanetti, G., Calandra, T., Glauser, M. P., Crokaert, F., Klastersky, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410502 · Cited by 370
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Self-citationNguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Raad, I., Hanna, H. A., Alakech, B., Chatzinikolaou, I., Johnson, M. M., & Tarrand, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00007 · Cited by 354
Self-citationFungal infections in patients with acute leukemia
Degregorio, M. W., Lee, W. M. F., Linker, C. A., Jacobs, R. A., & A. Ries, C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90334-5 · Cited by 354
Bacteraemia in febrile neutropenic cancer patients
Klastersky, J., Ameye, L., Maertens, J., Georgala, A., Muanza, F., Aoun, M., Ferrant, A., Rapoport, B., Rolston, K., & Paesmans, M. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.012 · Cited by 347
Self-citationMolecular Epidemiology of Bartonella Infections in Patients with Bacillary Angiomatosis–Peliosis
Koehler, J. E., Sanchez, M. A., Garrido, C. S., Whitfeld, M. J., Chen, F. M., Berger, T. G., Rodriguez-Barradas, M. C., LeBoit, P. E., & Tappero, J. W. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712253372603 · Cited by 346
Maertens, J., Van Eldere, J., Verhaegen, J., Verbeken, E., Verschakelen, J., & Boogaerts, M. (2002) · The Journal of Infectious Diseases · doi:10.1086/343804 · Cited by 343
Hachem, R., Hanna, H., Kontoyiannis, D., Jiang, Y., & Raad, I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 331
Self-citationMeta-Analysis: Methods for Diagnosing Intravascular Device–Related Bloodstream Infection
Safdar, N., Fine, J. P., & Maki, D. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00011 · Cited by 329
Weinstein, M. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.40 · Cited by 324
Boogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321
Self-citationVergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M., Schmitt, B., & Muder, R. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00007 · Cited by 319
Lodise, T. P., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., & McGregor, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-07 · Cited by 318
Clark, O. A. C., Lyman, G. H., Castro, A. A., Clark, L. G. O., & Djulbegovic, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.645 · Cited by 310
CONCURRENT LYME DISEASE AND BABESIOSIS: EVIDENCE FOR INCREASED SEVERITY AND DURATION OF ILLNESS.
&NA; (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199702000-00025 · Cited by 310
Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L., & Paul, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3851 · Cited by 298
Detection of Bacteremia in Adults: Consequences of Culturing an Inadequate Volume of Blood
Mermel, L. A., & Maki, D. G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00003 · Cited by 294
Nichols, W. G., Corey, L., Gooley, T., Davis, C., & Boeckh, M. (2001) · Blood · doi:10.1182/blood.v98.3.573 · Cited by 290
Self-citationBlot, F., Schmidt, E., Nitenberg, G., Tancrède, C., Leclercq, B., Laplanche, A., & Andremont, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.105-109.1998 · Cited by 289
Management of Fever in Neutropenic Patients with Different Risks of Complications
Klastersky, J. (2004) · Clinical Infectious Diseases · doi:10.1086/383050 · Cited by 287
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
Rubenstein, E. B., Rolston, K., Escalante, C., Manzullo, E., Hughes, P., Fender, A., Elting, L., Bodey, G. P., Holmes, F., Loewy, J., et al. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3640::aid-cncr2820711128>3.0.co;2-h · Cited by 286
Self-citationRecommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140952 · Cited by 281
Yokoe, D. S., Mermel, L. A., Anderson, D. J., Arias, K. M., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., Fraser, V., Gerding, D. N., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591060 · Cited by 280
Messing, B., Peitra‐Cohen, S., Debure, A., Beliah, M., & Bernier, J. (1988) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607188012002185 · Cited by 277
Cometta, A., Calandra, T., Gaya, H., Zinner, S. H., de Bock, R., Del Favero, A., Bucaneve, G., Crokaert, F., Kern, W. V., Klastersky, J., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1108 · Cited by 275
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267
Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265
Self-citationEfficacy and safety of cefepime: a systematic review and meta-analysis
Yahav, D., Paul, M., Fraser, A., Sarid, N., & Leibovici, L. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70109-3 · Cited by 265
Glasmacher, A., Prentice, A., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegovic, B., & Schmidt-Wolf, I. G. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.052 · Cited by 264
Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/527382 · Cited by 263
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
Gorschlüter, M., Mey, U., Strehl, J., Ziske, C., Schepke, M., Schmidt‐Wolf, I. G. H., Sauerbruch, T., & Glasmacher, A. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2005.00442.x · Cited by 262
Bow, E. J., Laverdière, M., Lussier, N., Rotstein, C., Cheang, M. S., & Ioannou, S. (2002) · Cancer · doi:10.1002/cncr.10610 · Cited by 258
Self-citationEfficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
Engels, E. A., Lau, J., & Barza, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1179 · Cited by 256
Boeckh, M., Kim, H. W., Flowers, M. E. D., Meyers, J. D., & Bowden, R. A. (2006) · Blood · doi:10.1182/blood-2005-09-3624 · Cited by 255
Self-citationRamphal, R. (2004) · Clinical Infectious Diseases · doi:10.1086/383048 · Cited by 252
Antimicrobial therapy of unexplained fever in neutropenic patients
Link, H., B�hme, A., Cornely, O. A., H�ffken, K., Kellner, O., Kern, W. V., Mahlberg, R., Maschmeyer, G., Nowrousian, M. R., Ostermann, H., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0764-4 · Cited by 251
Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-Analysis
Cruciani, M., Rampazzo, R., Malena, M., Lazzarini, L., Todeschini, G., Messori, A., & Concia, E. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.4.795 · Cited by 250
European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.5.951 · Cited by 246
“Low-Risk” Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia
Klaassen, R. J., Goodman, T. R., Pham, B., & Doyle, J. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1012 · Cited by 234
Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00077-07 · Cited by 232
Self-citationTrifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L., Evens, A., Winter, J., Tallman, M., Pi, J., & Mehta, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705754 · Cited by 229
De Pauw, B. E., Deresinski, S. C., Feld, R., Lane-Allman, E. F., & Donnelly, J. P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00004 · Cited by 228
Sulahian, A., Boutboul, F., Ribaud, P., Leblanc, T., Lacroix, C., & Derouin, F. (2001) · Cancer · doi:10.1002/1097-0142(20010115)91:2<311::aid-cncr1003>3.0.co;2-3 · Cited by 226
Predicting the risk of bacteremia in childen with fever and neutropenia.
Rackoff, W. R., Gonin, R., Robinson, C., Kreissman, S. G., & Breitfeld, P. B. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.919 · Cited by 223
Malik, I. A., Khan, W. A., Karim, M., Aziz, Z., & Ata Khan, M. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80367-2 · Cited by 221
Peck, A. J., Englund, J. A., Kuypers, J., Guthrie, K. A., Corey, L., Morrow, R., Hackman, R. C., Cent, A., & Boeckh, M. (2007) · Blood · doi:10.1182/blood-2006-12-060343 · Cited by 212
Self-citationFreifeld, A. G., Walsh, T., Marshall, D., Gress, J., Steinberg, S. M., Hathorn, J., Rubin, M., Jarosinski, P., Gill, V, & Young, R. C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.165 · Cited by 211
Self-citationValue of differential quantitative blood cultures in the diagnosis of catheter-related sepsis
Capdevila, J. A., Planes, A. M., Palomar, M., Gasser, I., Almirante, B., Pahissa, A., Crespo, E., & Martínez-Vázquez, J. M. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01961854 · Cited by 210
Weinstock, D. M., Conlon, M., Iovino, C., Aubrey, T., Gudiol, C., Riedel, E., Young, J. W., Kiehn, T. E., & Zuccotti, G. (2007) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.01.078 · Cited by 208
Self-citationFluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Antibiotic prophylaxis in neutropenic patients: New evidence, practical decisions
Leibovici, L., Paul, M., Cullen, M., Bucaneve, G., Gafter‐Gvili, A., Fraser, A., & Kern, W. V. (2006) · Cancer · doi:10.1002/cncr.22205 · Cited by 203
Robertson, J. D., Nagesh, K., Jowitt, S. N., Dougal, M., Anderson, H., Mutton, K., Zambon, M., & Scarffe, J. H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1088 · Cited by 199
(1995) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(05)80058-6 · Cited by 197
Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., Sheridan, W. P., Kefford, R. F., Cebon, J., Olver, I., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00004 · Cited by 196
the EORTC International Antimicrobial Therapy Cooperative Group, Cometta, A., & Program, T. G. I. (1997) · Febrile Neutropenia · doi:10.1007/978-3-642-60443-0_16 · Cited by 196
Krishna, G., Martinho, M., Chandrasekar, P., Ullmann, A. J., & Patino, H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1627 · Cited by 195
Klastersky, J., Paesmans, M., Georgala, A., Muanza, F., Plehiers, B., Dubreucq, L., Lalami, Y., Aoun, M., & Barette, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9909 · Cited by 195
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis
Guo, Y.-L., Chen, Y.-Q., Wang, K., Qin, S.-M., Wu, C., & Kong, J.-L. (2010) · Chest · doi:10.1378/chest.10-0488 · Cited by 194
SARAL, R., AMBINDER, R. F., BURNS, W. H., ANGELOPULOS, C. M., GRIFFIN, D. E., BURKE, P. J., & LIETMAN, P. S. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-6-773 · Cited by 191
Cyclophosphamide metabolism is affected by azole antifungals
Marr, K. A., Leisenring, W., Crippa, F., Slattery, J. T., Corey, L., Boeckh, M., & McDonald, G. B. (2004) · Blood · doi:10.1182/blood-2003-07-2512 · Cited by 190
Self-citationSoares, J., Pinto, A. E., Cunha, C. V., Andr�, S., Bar�o, I., Sousa, J. M., & Cravo, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<112::aid-cncr16>3.0.co;2-t · Cited by 187
DesJardin, J. A., Falagas, M. E., Ruthazer, R., Griffith, J., Wawrose, D., Schenkein, D., Miller, K., & Snydman, D. R. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00002 · Cited by 177
Paul, M., Dickstein, Y., Schlesinger, A., Grozinsky-Glasberg, S., Soares-Weiser, K., & Leibovici, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038.pub2 · Cited by 177
Garcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Dietary factors and the risk of endometrial cancer
Levi, F., La Vecchia, C., Franceschi, S., & Negri, E. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3575::aid-cncr2820711119>3.0.co;2-0 · Cited by 176
Tronko, M. D., Bogdanova, T. I., Komissarenko, I. V., Epstein, O. V., Oliynyk, V., Kovalenko, A., Likhtarev, I. A., Kairo, I., Peters, S. B., & LiVolsi, V. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1<149::aid-cncr21>3.0.co;2-a · Cited by 175
Jaksic, B., Martinelli, G., Oteyza, J. P., Hartman, C. S., Leonard, L. B., & Tack, K. J. (2006) · Clinical Infectious Diseases · doi:10.1086/500139 · Cited by 170
Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376637 · Cited by 168
Mattiuzzi, G. N., Alvarado, G., Giles, F. J., Ostrosky-Zeichner, L., Cortes, J., O'Brien, S., Verstovsek, S., Faderl, S., Zhou, X., Raad, I. I., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.143-147.2006 · Cited by 168
Self-citationSegal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007) · Clinical Infectious Diseases · doi:10.1086/510677 · Cited by 168
Self-citationOliveira, A. L., de Souza, M., Carvalho-Dias, V. M. H., Ruiz, M. A., Silla, L., Tanaka, P. Y., Simões, B. P., Trabasso, P., Seber, A., Lotfi, C. J., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705677 · Cited by 168
An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis
Karp, J. E., Burch, P. A., & Merz, W. G. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80343-7 · Cited by 164
Pinto, L., Liu, Z., Doan, Q., Bernal, M., Dubois, R., & Lyman, G. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219599 · Cited by 163
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
Elting, L. S., Lu, C. S., Escalante, C. P., Giordano, S. H., Trent, J. C., Cooksley, C. D., Avritscher, E. B. C., Shih, Y. T., Ensor, J., Bekele, B. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8222 · Cited by 163
Self-citationHistoplasmosis-Associated Cross-Reactivity in the BioRad Platelia Aspergillus Enzyme Immunoassay
Wheat, L. J., Hackett, E., Durkin, M., Connolly, P., Petraitiene, R., Walsh, T. J., Knox, K., & Hage, C. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00479-06 · Cited by 162
Staphylococcus aureus bacteremia in patients with Hickman catheters
Dugdale, D. C., & Ramsey, P. G. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90290-t · Cited by 161
Winston, D. J., Ho, W. G., Bruckner, D. A., & Champlin, R. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-849 · Cited by 161
DiazGranados, C. A., & Jernigan, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427512 · Cited by 160
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
Mullen, C. A., Petropoulos, D., Roberts, W. M., Rytting, M., Zipf, T. F., Chan, K. W., Culbert, S. J., Danielson, M., Jeha, S. S., Kuttesch, J. F., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1<126::aid-cncr18>3.0.co;2-1 · Cited by 160
Self-citationManagement of central venous catheters in patients with cancer and candidemia
Raad, I., Hanna, H., Boktour, M., Girgawy, E., Danawi, H., Mardani, M., Kontoyiannis, D., Darouiche, R., Hachem, R., & Bodey, G. P. (2004) · Clinical Infectious Diseases · doi:10.1086/382874 · Cited by 159
Self-citationVoriconazole concentrations and outcome of invasive fungal infections
Miyakis, S., van Hal, S. J., Ray, J., & Marriott, D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02990.x · Cited by 159
Bacillary Angiomatosis and Bacillary Splenitis in Immunocompetent Adults
Tappero, J. W., Koehler, J. E., Berger, T. G., Cockerell, C. J., Lee, T.-H., Busch, M. P., Stites, D. P., Mohle-Boetani, J., Reingold, A. L., & LeBoit, P. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-5-199303010-00007 · Cited by 158
Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report
HAMPEL, B., HULLMANN, R., & SCHMIDT, H. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199701000-00036 · Cited by 158
Benoit, J.-L., Carandang, G., Sitrin, M. D., & Arnow, P. M. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1286 · Cited by 154
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1611::aid-cncr27>3.0.co;2-b · Cited by 154
Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters
Raucher, H. S., Hyatt, A. C., Barzilai, A., Harris, M. B., Weiner, M. A., LeLeiko, N. S., & Hodes, D. S. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80584-3 · Cited by 153
Cattaneo, C. M., Quaresmini, G., Casari, S., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm514 · Cited by 153
Kern, W. V., Klose, K., Jellen-Ritter, A., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1278-x · Cited by 152
Gardner, A., Mattiuzzi, G. N., Faderl, S. H., Borthakur, G. M., Garcia‐Manero, G., Pierce, S. A., Brandt, M., & Estey, E. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4681 · Cited by 152
Favero, A. D., Menichetti, F., Martino, P., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322646 · Cited by 150
Vancomycin‐ResistantStaphylococcus aureusin the Absence of Vancomycin Exposure
Whitener, C., Park, S. Y., Browne, F. A., Parent, L. J., Julian, K. G., Bozdoğan, B., Appelbaum, P. C., Chaitram, J. M., Weigel, L. M., Jernigan, J. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/382357 · Cited by 148
Pinel, C., Fricker‐Hidalgo, H., Lebeau, B., Garban, F., Hamidfar, R., Ambroise-Thomas, P., & Grillot, R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.2184-2186.2003 · Cited by 146
von Lilienfeld‐Toal, M., Dietrich, M. P., Glasmacher, A. G., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1156-y · Cited by 146
Paul, M., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 145
Loehrer, P. J. (2008) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)79021-3 · Cited by 144
Symeonidis, N., Jakubowski, A. A., Pierre‐Louis, S., et al. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00184.x · Cited by 143
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · PubMed · Cited by 137
Malik, I. A., Abbas, Z., Karim, M. O., & Malik, I. A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90674-r · Cited by 135
Fleming, R. V., Kantarjian, H. M., Husni, R., Rolston, K. V. I., Lim, J. T., RAAD, I. I., Pierce, S. A., Cortes, J. E., & Estey, E. H. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097650 · Cited by 134
Self-citationEmpiric antibiotic therapy for granulocytopenic cancer patients.
Sc, S. (1986) · PubMed · Cited by 133
Innes, H., Smith, D. B., O'Reilly, S. M., CLARK, P. I., Kelly, V., & Marshall, E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600993 · Cited by 133
Bacteremic Pneumonia in Neutropenic Patients With Cancer
Carratalà, J., Rosón, B., Fernández-Sevilla, A., Alcaide, F., & Gudiol, F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.868 · Cited by 132
Lin, P. P., Schupak, K. D., Boland, P. J., Brennan, M. F., & Healey, J. H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2391::aid-cncr13>3.0.co;2-k · Cited by 131
Reuter, S., Kern, W. V., Sigge, A., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428732 · Cited by 131
Razonable, R. R., Litzow, M. R., Khaliq, Y., Piper, K. E., Rouse, M. S., & Patel, R. (2002) · Clinical Infectious Diseases · doi:10.1086/340352 · Cited by 130
Vardakas, K. Z., Michalopoulos, A. S., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Research works printed but not linked: 7
- Owens, 2000, Reduction in vancomycin consumption in patients with fever and neutropenia, Clin Infect Dis, 31, 291
- Rotstein, 1997, Fluoroquinolone prophylaxis for profoundly neutropenic cancer patients: a meta-analysis, Opin Oncol, 4, 2
- Pasqualotto, 2006, Antibacterial prophylaxis in patients with cancer and neutropenia, N Engl J Med, 354, 90, 10.1056/NEJMc052613 · DOI
- Ito, 2006, Antibacterial prophylaxis in patients with cancer and neutropenia, N Engl J Med, 354, 90, 10.1056/NEJMc052613 · DOI
- Greene, 2007, Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign, Clin Infect Dis, 44, 373, 10.1086/509917 · DOI · Paper page
- Marks, 2009, Voriconazole (VOR) vs itraconazole (ITR) for primary prophylaxis of invasive fungal infection (IFI) in allogeneic hematopoietic cell transplant (HCT) recipients [abstract M-1249a]
- National Cancer Center Network (NCCN), 2009, Myeloid growth factors: NCCN practice guidelines
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citation
Metadata
- Authors
- Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R.
- Affiliations
- University of Nebraska Medical Center (US)
- CancerCare Manitoba (CA)
- Memorial Sloan Kettering Cancer Center (US)
- Fred Hutch Cancer Center (US)
- City Of Hope National Medical Center (US)
- University of Rochester Medicine (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Minnesota (US)
- University of Florida (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-15
- Volume
- 52
- Issue
- 4
- Pages
- e56-e93
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2123859227
- Semantic Scholar
- 61f444a63e765b8981339be50b8136ae0b15cb08
- Cited by
- 3,463
- References
- 360
- Citations by year
- 2026: 176 · 2025: 180 · 2024: 163 · 2023: 211 · 2022: 233 · 2021: 245 · 2020: 260 · 2019: 277 · 2018: 254 · 2017: 267 · 2016: 218 · 2015: 247 · 2014: 248 · 2013: 221 · 2012: 174
- FWCI
- 112.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- febrile neutropenia, cancer, chemotherapy-induced neutropenia, antibiotic prophylaxis, antifungal prophylaxis, antiviral prophylaxis, risk stratification, invasive fungal infections, preemptive antifungal therapy, empirical antibiotic therapy, infection management
- MeSH terms
- Anti-Infective Agents, Antineoplastic Agents, Canada, Communicable Diseases, Fever of Unknown Origin, Humans, Neoplasms, Neutropenia, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.